TABLE OF CONTENTS

Volume 66, Issue S92 (November 2004)

Top

Original Articles

Introduction FREE

DICK DE ZEEUW, GEORGE BAKRIS and MARC A PFEFFER

Kidney Int 66: S1-S1; doi:10.1111/j.1523-1755.2004.09200.x

Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? FREE

DICK DE ZEEUW

Kidney Int 66: S2-S6; doi:10.1111/j.1523-1755.2004.09201.x

Top

Overviews

Trends in the incidence of treated end-stage renal failure in The Netherlands: Hope for the future? FREE

RON T GANSEVOORT, BART VAN DER HEIJ, COEN A STEGEMAN, FRANKDE CHARRO, MARTIN G NIEUWENHUIZEN, DICK DE ZEEUW and PAULDE JONG

Kidney Int 66: S7-S10; doi:10.1111/j.1523-1755.2004.09202.x

Cardiovascular risk in chronic kidney disease FREE

NAGESH S ANAVEKAR and MARC A PFEFFER

Kidney Int 66: S11-S15; doi:10.1111/j.1523-1755.2004.09203.x

Which albumin should we measure? FREE

GAVIN J BECKER

Kidney Int 66: S16-S17; doi:10.1111/j.1523-1755.2004.09204.x

Top

Albuminuria Predicting Outcome in the General Populations

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population FREE

JACOBIEN C VERHAVE, RON T GANSEVOORT, HANS L HILLEGE, STEPHAN J L BAKKER, DICK DE ZEEUW, PAULDE JONG and PREVEND S

Kidney Int 66: S18-S21; doi:10.1111/j.1523-1755.2004.09205.x

Prevalence of albuminuria in Australia: The AusDiab Kidney Study FREE

ROBERT C ATKINS, KEVAN R POLKINGHORNE, ESTHER M BRIGANTI, JONATHAN E SHAW, PAUL Z ZIMMET and STEVEN J CHADBAN

Kidney Int 66: S22-S24; doi:10.1111/j.1523-1755.2004.09206.x

Albuminuria: Marker or target in indigenous populations FREE

WENDY HOY and STEPHEN P MCDONALD

Kidney Int 66: S25-S31; doi:10.1111/j.1523-1755.2004.09207.x

Demographic and epidemiologic transition in the developing world: Role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease FREE

RICARDO CORREA-ROTTER, SARALA NAICKER, IVOR J KATZ, SANJAY K AGARWAL, RAUL HERRERA VALDES, DAN KASEJE, BERNARDO RODRIGUEZ-ITURBE, FAISSAL SHAHEEN, CHITR SITTHI-AMORN and ISN-COMGAN B

Kidney Int 66: S32-S37; doi:10.1111/j.1523-1755.2004.09208.x

Top

Albuminuria Predicting Outcome in Diabetes

Albuminuria predicting outcome in diabetes: Incidence of microalbuminuria in Asia–Pacific Rim FREE

MATTHEW R WEIR

Kidney Int 66: S38-S39; doi:10.1111/j.1523-1755.2004.09209.x

Microalbuminuria, glycemic control, and blood pressure predicting outcome in diabetes type 1 and type 2 FREE

CARL ERIK MOGENSEN and PER LOGSTRUP POULSEN

Kidney Int 66: S40-S41; doi:10.1111/j.1523-1755.2004.09210.x

Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction—The Hoorn Study FREE

COEN D A STEHOUWER, RONALD M A HENRY, JACQUELINE M DEKKER, GIEL NIJPELS, ROBERT J HEINE and LEX M BOUTER

Kidney Int 66: S42-S44; doi:10.1111/j.1523-1755.2004.09211.x

Top

Albuminuria Predicting Outcome in Heart Diseases

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension FREE

JULIAN SEGURA, CARLOS CAMPO and LUIS M RUILOPE

Kidney Int 66: S45-S49; doi:10.1111/j.1523-1755.2004.09212.x

Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria FREE

NAGESH S ANAVEKAR, DANIEL J GANS, TOMAS BERL, RICHARD D ROHDE, WILLIAM COOPER, AMITABHA BHAUMIK, LAWRENCE G HUNSICKER, JEAN-LUCIEN ROULEAU, JULIA B LEWIS, CLIVE ROSENDORFF, JEROME G PORUSH, PAUL L DRURY, ENRIC ESMATJES, ITAMAR RAZ, PHILLIPPE VANHILLE, FRANCESO LOCATELLI, SAMUEL GOLDHABER, EDMUND J LEWIS and MARC A PFEFFER

Kidney Int 66: S50-S55; doi:10.1111/j.1523-1755.2004.09213.x

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study FREE

HANS IBSEN, KRISTIAN WACHTELL, MICHAEL H OLSEN, KNUT BORCH-JOHNSEN, LARS H LINDHOLM, CARL ERIK MOGENSEN and BJÖRN DAHLÖF

Kidney Int 66: S56-S58; doi:10.1111/j.1523-1755.2004.09214.x

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease FREE

JOHANNES F E MANN, QI-LONG YI and HERTZEL C GERSTEIN

Kidney Int 66: S59-S62; doi:10.1111/j.1523-1755.2004.09215.x

Top

Mechanism and Measurement of Albuminuria

Glomerular filtration of albumin: How small is the sieving coefficient? FREE

WILLIAM M DEEN and MATTHEW J LAZZARA

Kidney Int 66: S63-S64; doi:10.1111/j.1523-1755.2004.09216.x

Albumin-like material in urine FREE

WAYNE D COMPER and TANYA M OSICKA

Kidney Int 66: S65-S66; doi:10.1111/j.1523-1755.2004.09217.x

Mechanism of albuminuria associated with cardiovascular disease and kidney disease FREE

LEILEATA M RUSSO, WAYNE D COMPER and TANYA M OSICKA

Kidney Int 66: S67-S68; doi:10.1111/j.1523-1755.2004.09218.x

Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC FREE

JACOLINE W BRINKMAN, STEPHAN J L BAKKER, RON T GANSEVOORT, HANS L HILLEGE, IDO P KEMA, REINOLD O B GANS, PAULDE JONG and DICK DE ZEEUW

Kidney Int 66: S69-S75; doi:10.1111/j.1523-1755.2004.09219.x

Why is proteinuria an ominous biomarker of progressive kidney disease? FREE

KAMBIZ ZANDI-NEJAD, ALLISON A EDDY, RICHARD J GLASSOCK and BARRY M BRENNER

Kidney Int 66: S76-S89; doi:10.1111/j.1523-1755.2004.09220.x

Top

Albuminuria Predicting Outcome in Renal Diseases

Proteinuria predicting outcome in renal disease: Nondiabetic nephropathies (REIN) FREE

GIUSEPPE REMUZZI, CARLOS CHIURCHIU and PIERO RUGGENENTI

Kidney Int 66: S90-S96; doi:10.1111/j.1523-1755.2004.09221.x

Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease FREE

WILLIAM E MITCH, SHAHNAZ SHAHINFAR, TANIA Z DICKSON, DICK DE ZEEUW and ZHONGXIN ZHANG

Kidney Int 66: S97-S98; doi:10.1111/j.1523-1755.2004.09222.x

Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial FREE

LAWRENCE G HUNSICKER, ROBERT C ATKINS, JULIA B LEWIS, GREGORY BRADEN, PAUL J CHAMPION DE CRESPIGNY, GIACOMO DEFERRARI, PAUL DRURY, FRANCESCO LOCATELLI, THOMAS B WIEGMANN, EDMUND J LEWIS and C

Kidney Int 66: S99-S101; doi:10.1111/j.1523-1755.2004.09223.x

Proteinuria and hypertensive nephrosclerosis in African Americans FREE

ROBERT D TOTO

Kidney Int 66: S102-S104; doi:10.1111/j.1523-1755.2004.09224.x

Top

Albuminuria as a Therapy Target for Renal-CV Protections

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes FREE

JOSEPHINE M FORBES, MERLIN C THOMAS, SUZANNE R THORPE, NATHAN L ALDERSON and MARK E COOPER

Kidney Int 66: S105-S107; doi:10.1111/j.1523-1755.2004.09225.x

Beneficial impact on cardiovascular risk factors by dual blockade of the renin-angiotensin system in diabetic nephropathy FREE

PETER JACOBSEN and HANS-HENRIK PARVING

Kidney Int 66: S108-S110; doi:10.1111/j.1523-1755.2004.09226.x

Framingham score and microalbuminuria: Combined future targets for primary prevention? FREE

FOLKERT W ASSELBERGS, HANS L HILLEGE and WIEKVAN GILST

Kidney Int 66: S111-S114; doi:10.1111/j.1523-1755.2004.09227.x

Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy FREE

CHARLES M ALEXANDER, PAULETTE A LYLE, WILLIAM F KEANE, GEORGE W CARIDES, ZHONGXIN ZHANG and SHAHNAZ SHAHINFAR

Kidney Int 66: S115-S117; doi:10.1111/j.1523-1755.2004.09228.x

Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria FREE

ANDREW J PALMER and ROGER A RODBY

Kidney Int 66: S118-S120; doi:10.1111/j.1523-1755.2004.09229.x

Top

Inclusion of Albumin as a Target in Therapy Guidelines

Inclusion of albumin as a target in therapy guidelines: Guidelines for chronic kidney disease FREE

DAVID G WARNOCK

Kidney Int 66: S121-S123; doi:10.1111/j.1523-1755.2004.09230.x

Inclusion of albuminuria in hypertension and heart guidelines FREE

GEORGE BAKRIS

Kidney Int 66: S124-S125; doi:10.1111/j.1523-1755.2004.09231.x

Albuminuria as a surrogate marker for drug development: A European Regulatory perspective FREE

GONZALO CALVO and FERNANDO DE ANDRES-TRELLES

Kidney Int 66: S126-S127; doi:10.1111/j.1523-1755.2004.09232.x

Extra navigation

.
ADVERTISEMENT